Publication | Closed Access

Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP

NeurophysiologyMedicineMonoamine NeurotransmittersPsychopharmacologyNeuropharmacologyChronic PretreatmentNorepinephrine MetabolismNeuroscienceDopaminePharmacologyNeurochemistrySocial SciencesAcute Administration